Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Nov 17;12(1):31.
doi: 10.1186/s13722-017-0095-8.

Testing the effectiveness of a motivational interviewing-based brief intervention for substance use as an adjunct to usual care in community-based AIDS service organizations: study protocol for a multisite randomized controlled trial

Affiliations

Testing the effectiveness of a motivational interviewing-based brief intervention for substance use as an adjunct to usual care in community-based AIDS service organizations: study protocol for a multisite randomized controlled trial

Bryan R Garner et al. Addict Sci Clin Pract. .

Erratum in

Abstract

Background: In 2010, the first comprehensive National HIV/AIDS Strategy for the United States was released and included three goals: (1) reducing the number of people who become infected with HIV, (2) increasing access to care and improving health outcomes for people living with HIV, and (3) reducing HIV-related health disparities and health inequities. In 2013, as part of its effort to help address the National HIV/AIDS Strategy, the National Institute on Drug Abuse (NIDA) funded a type 2 effectiveness-implementation hybrid trial titled the Substance Abuse Treatment to HIV Care (SAT2HIV) Project. Aim 1 of the SAT2HIV Project tests the effectiveness of a motivational interviewing-based brief intervention (MIBI) for substance use as an adjunct to usual care within AIDS Service Organizations (ASOs) as part of its MIBI Experiment. Aim 2 of the SAT2HIV Project tests the effectiveness of implementation and sustainment facilitation (ISF) as an adjunct to the Addiction Technology Transfer Center (ATTC) model for training staff in motivational interviewing as part of its ISF Experiment. The current paper describes the study protocol for the MIBI Experiment.

Methods: As part of a multisite randomized controlled trial, individuals with comorbid HIV/AIDS and problematic substance use are randomized to receive either the ASOs' usual care (control condition) or usual care plus a MIBI for substance use (experimental condition) delivered by trained ASO case-management staff. Primary outcome measures are reductions in days of primary substance use, number of substance-related problems, times engaging in risky behaviors, days of non-adherence to HIV medications, and increases in substance use treatment. As part of this paper, we describe the trial protocol in accordance with the Standard Protocol Items: Recommendations for Interventional Trials guidelines.

Discussion: If successfully able to implement MIBI as an effective adjunct to usual care, the current trial may have a significant impact on increasing the capacity of ASOs to address problematic substance use among individuals living with HIV/AIDS. Reducing the prevalence of problematic substance use among individuals living with HIV/AIDS within the United States may lead to significant improvements on key performance measures (i.e., the HIV Care Continuum and the 90-90-90 target). Trial registration ClinicalTrials.gov: NCT02495402.

Keywords: AIDS; HIV; Substance use; type 2 hybrid trial.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Conceptual overview of the MIBI experiment within the context of the parent SAT2HIV Project. Note: MIBI = Motivational Interviewing-based Brief Intervention; ISF = Implementation and Sustainment Facilitation; bolded arrows represent hypothesized relationships. Dashed arrows represent interactions and cross-level interactions that will be examined
Fig. 2
Fig. 2
Visual illustration of the multi-step motivational interviewing-based brief intervention (MIBI)
Fig. 3
Fig. 3
Flow of participants
Fig. 4
Fig. 4
Potential impacts of the SAT2HIV Project’s MIBI Experiment

References

    1. White House Office of National AIDS Policy. National HIV/AIDS strategy for the United States. Updated to 2020. https://www.aids.gov/federal-resources/national-hiv-aids-strategy/nhas-u... (2015). Accessed 28 Aug 2015.
    1. Centers for Disease Control and Prevention. New HIV infections in the United States. https://www.cdc.gov/nchhstp/newsroom/docs/factsheets/new-hiv-infections-... (2016). Accessed 10 Jan 2017.
    1. Centers for Disease Control and Prevention. HIV cost-effectiveness. http://www.cdc.gov/hiv/prevention/ongoing/costeffectiveness/ (2013). Accessed 28 Aug 2015.
    1. Bradley H, Hall HI, Wolitski RJ, Van Handel MM, Stone AE, LaFlam M, Skarbinski J, Higa DH, Prejean J, Frazier EL, et al. Vital Signs: HIV diagnosis, care, and treatment among persons living with HIV–United States, 2011. MMWR Morb Mortal Wkly Rep. 2014;63(47):1113–1117. - PMC - PubMed
    1. Insight Start Study Group. Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, Sharma S, Avihingsanon A, Cooper DA, Fatkenheuer G, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795–807. doi: 10.1056/NEJMoa1506816. - DOI - PMC - PubMed

Publication types

Associated data